Clinical impact of breast MRI with regard to axillary reverse mapping in clinically node positive breast cancer patients following neo-adjuvant chemotherapy
Beek, M.A, Tetteroo, E, Luiten, E.J.T, Gobardhan, P.D, Rutten, H.J.T, Heijns, J.B, Voogd, A.C, Klompenhouwer, E.G
Published in European journal of surgical oncology (01.05.2016)
Published in European journal of surgical oncology (01.05.2016)
Get full text
Journal Article
377P Phase II study of trifluridine/tipiracil in pre-treated patients with ER-positive, HER2-negative metastatic breast cancer: A Dutch BOOG (2019-01 TIBET) study
Guchelaar, N.A.D., Mathijssen, R.H., De Boer, M., van Bekkum, M.L., Heijns, J.B., Vriens, B.E.P.J., Kessels, L.W., Hamming, L.C., Beelen, K.J., Nieboer, P., van Rosmalen, M.M., van den Berg, S.M., Hoop, E. Oomen-de, Bijlsma, R.M., Bos, M.M.E.M.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
395P Receptor status heterogeneity during metastatic breast cancer treatment
Geurts, S., Hermans, K., Van den Berkmortel, F., Tol, J., Heijns, J.B., Dercksen, M., Vriens, B.E.P.J., Aaldering, K., Pepels, M., Peters, N., van de Winkel, L., Boon, E., Teeuwen, N., van Kats, M., Tjan-Heijnen, V.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
392P The prognostic impact of BMI in patients with HR+/HER2- advanced breast cancer on first-line endocrine therapy with or without a CDK 4/6 inhibitor
Lammers, S., Thurisch, H., Vriens, I.J.H., Meegdes, M., Engelen, S.M.E., Erdkamp, F.L.G., Dercksen, M., Vriens, B., Aaldering, K., Pepels, M., Winkel, L.V.D., Peters, N., Tol, J., Heijns, J.B., van de Wouw, A., Teeuwen, N., Geurts, S., Tjan-Heijnen, V.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
LBA20 First-line carboplatin-cyclophosphamide (CC) versus paclitaxel (P) with or without atezolizumab (atezo) for metastatic triple negative breast cancer (mTNBC): Results from a multicenter, randomized phase IIb trial: The Triple-B study (BOOG 2013-01)
Kok, M., Voorthuis, R.A.B., De Boo, L., van Rossum, A.G.J., Mandjes, I., Balduzzi, S., Chelushkin, M., Rosenberg, E.H., Horlings, H.M., Loo, C.E., Heijns, J.B., Agterhof, M., De Valk, B., Riel, A-M.V., Van Der Velden, A., Dercksen, M., Imholz, A., van Leeuwen-Stok, A.E., Oosterkamp, H.M., Linn, S.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
179P Time trends in overall survival and systemic therapy in patients with HR+/HER2- advanced breast cancer: A study of the SONABRE registry
Meegdes, M., Geurts, S.M.E., Erdkamp, F.L.G., Dercksen, W., Vriens, B.E.P.J., Aaldering, K.N.A., Pepels, M.J.A.E., Winkel, L.V.D., Tol, J., Heijns, J.B., van de Wouw, A.J., Peters, N., Fallois, A.J.O., van Kats, M.A.C.E., Tjan-Heijnen, V.C.G.
Published in Annals of oncology (01.05.2022)
Published in Annals of oncology (01.05.2022)
Get full text
Journal Article
180P A doubling in overall survival of patients with de novo HER2+ advanced breast cancer in the Netherlands
Geurts, S.M.E., Ibragimova, K., Meegdes, M., Erdkamp, F.L.G., Heijns, J.B., Tol, J., Vriens, B.E.P.J., Dercksen, W., Aaldering, K.N.A., Pepels, M.J.A.E., Winkel, L.V.D., Peters, N., van de Wouw, A.J., Hochstenbach, A., De Boer, M., Tjan-Heijnen, V.C.G.
Published in Annals of oncology (01.05.2022)
Published in Annals of oncology (01.05.2022)
Get full text
Journal Article
202P Complete response rates, treatment patterns and survival outcomes in patients treated with first-line pertuzumab-based therapy in HER2-positive advanced breast cancer: A SONABRE study
Ding, N., Geurts, S.M.E., Tol, J., Vriens, B.E.P.J., Aaldering, K.N.A., Boon, E., Dercksen, M.W., Van den Berkmortel, F., Pepels, M.J.A.E., Peters, N.A.J.B., Heijns, J.B., Winkel, L.V.D., de Fallois, A.J.O., Tjan-Heijnen, V.C.G., De Boer, M.
Published in ESMO open (01.05.2024)
Published in ESMO open (01.05.2024)
Get full text
Journal Article
233P Treatment pattern and outcomes for the first two lines of chemotherapy in patients diagnosed with metastatic triple-negative breast cancer, results from the Dutch SONABRE Registry
Geurts, S.M.E., Ding, N., Meegdes, M., Erdkamp, F.L.G., Heijns, J.B., Tol, J., Vriens, B., Dercksen, W., Aaldering, K., Pepels, M., Winkel, L.V.D., Peters, N., van de Wouw, A., Teeuwen, N., De Boer, M., Tjan-Heijnen, V.C.G.
Published in ESMO open (01.05.2023)
Published in ESMO open (01.05.2023)
Get full text
Journal Article
219P Chemotherapy use and survival outcomes for patients diagnosed with metastatic hormone receptor-positive HER2-negative breast cancer, results from the Dutch SONABRE registry
Geurts, S.M.E., Meegdes, M., Ding, N., Erdkamp, F.L.G., Heijns, J.B., Tol, J., Vriens, B., Dercksen, W., Aaldering, K., Pepels, M., Winkel, L.V.D., Peters, N., van de Wouw, A., Fallois, A., Vriens, I.J.H., Tjan-Heijnen, V.C.G.
Published in ESMO open (01.05.2023)
Published in ESMO open (01.05.2023)
Get full text
Journal Article
Addition of zoledronic acid to neoadjuvant chemotherapy does not enhance tumor response in patients with HER2-negative stage II/III breast cancer: the NEOZOTAC trial (BOOG 2010-01)
Charehbili, A., van de Ven, S., Smit, V.T.H.B.M., Meershoek-Klein Kranenbarg, E., Hamdy, N.A.T., Putter, H., Heijns, J.B., van Warmerdam, L.J.C., Kessels, L., Dercksen, M., Pepels, M.J., Maartense, E., van Laarhoven, H.W.M., Vriens, B., Wasser, M.N., van Leeuwen-Stok, A.E., Liefers, G.J., van de Velde, C.J.H., Nortier, J.W.R., Kroep, J.R.
Published in Annals of oncology (01.05.2014)
Published in Annals of oncology (01.05.2014)
Get full text
Journal Article